NCT07771790

Brief Summary

The goal of this study is to determine whether consuming a commercially available exogenous ketone supplement (KetoneIQ®) affects cognition, specifically marksmanship, under physical stress (i.e., exhaustive exercise). The main questions we seek to answer are:

  • Does the supplement save cognitive performance under stress compared to a placebo?
  • Does the supplement improve marksmanship under stress compared to a placebo?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Sep 2026May 2027

First Submitted

Initial submission to the registry

August 10, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 18, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Last Updated

September 2, 2026

Status Verified

August 1, 2026

Enrollment Period

9 months

First QC Date

August 10, 2026

Last Update Submit

August 29, 2026

Conditions

Keywords

Exogenous KetonesCognitionTactical Athlete

Outcome Measures

Primary Outcomes (1)

  • Cognitive Performance

    Changes in Score for the Trail Making Test, Psychomotor Vigilance Test, and Flanker Test.

    Baseline (minute 0) to Post Suppelementation (minute 45) to Post Exercise (minute 60)

Secondary Outcomes (5)

  • Changes in Circulating Concentration of Brain Derieved Neurotrophic Factor

    Baseline (minute 0) to post supplementation (minute 45) to post exercise (minute 60)

  • Changes in Circulating Catecholamines Concetrations

    From baseline (minute 0) to post supplemenation (minute 45) to post exercise (minute 60)

  • Changes in Circulating Cortisol Concentration

    From baseline (minute 0) to post supplemetation (minute 45) to post exercise (minute 60)

  • Weapons Familarization Score

    Post Exercise (minute 60)

  • Marksmanship efficiency

    Post Exercise (minute 60)

Study Arms (2)

KetoneIQ®

EXPERIMENTAL

Supplement of study. KetoneIQ® dosed at 0.6g/kg body weight

Dietary Supplement: KetoneIQ®

Placebo

PLACEBO COMPARATOR

Flavor, texture, color matched. Very low calorie.

Dietary Supplement: Placebo

Interventions

KetoneIQ®DIETARY_SUPPLEMENT

Acute dosage at 0.6g/kg of bodyweight, split into 2 boluses of 0.4 and 0.2g/kg seperated by 45 mins

KetoneIQ®
PlaceboDIETARY_SUPPLEMENT

Taste, texture, and color matched very low calorie placebo

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Active Member of an accredited Law Enforcement Special Weapons and Tactics Team (SWAT)
  • Health and capable of meeting testing requirements

You may not qualify if:

  • Following a low-carbohydrate ketogenic diet
  • Self-reported Pregnancy
  • Allergy to testing materials
  • Currently using exogenous ketone supplements within one week of testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Sports Sciences and Medicine

Tallahassee, Florida, 32306, United States

RECRUITING

Study Officials

  • Michael J Ormsbee, PhD

    Florida State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael J Ormsbee, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 10, 2026

First Posted

August 18, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

May 31, 2027

Last Updated

September 2, 2026

Record last verified: 2026-08

Locations